Huangming Hong

University of Electronic Science and Technology of China

Also affiliated with Sichuan Cancer Hospital

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “823 | A PHASE IA/IB OPEN‐LABEL STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMIC OF UBX‐303061 IN PATIENTS WITH RELAPSED/REFRACTORY B‐CELL MALIGNANCIES”.

823 | A PHASE IA/IB OPEN‐LABEL STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMIC OF UBX‐303061 IN PATIENTS WITH RELAPSED/REFRACTORY B‐CELL MALIGNANCIES

Hematological Oncology(2025)10.1002/hon.70096_823

N/A

0DataRank · unranked

0 citations

Dok Hyun Yoon, Ki‐Seong Eom, Yeon Soo Jeon, Sukhyang Lee, J. Ryu +4 more